Clinical Trial Update: Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prednisolone acetate 0.5% cream with betamethasone valerate 0.1% cream to assess efficacy and tolerability in corticosensitive dermatose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Psoriasis
• Seborrheic Dermatitis

Drugs mentioned

• Betamethasone Valerate 0.1% Cream (betamethasone valerate)
• Prednisolone Acetate 0.5% Cream (prednisolone acetate)

Snippet

Sponsor: Mantecorp Industria Quimica e Farmaceutica Ltd. | Conditions: Dermatitis, Atopic, Dermatitis, Contact | Phase 3 | Status: UNKNOWN